COLL

Dopo l'orario di chiusura: 32.31

Collegium Pharmaceutical Inc (COLL)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Collegium Pharmaceutical Inc Stock (COLL) Company Profile

Collegium Pharmaceutical Inc

Healthcare (1118)

781-713-3699

100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA

Prossima data di guadagno

Ultimi documenti SEC

COLL's Discussions on Twitter

Compare COLL vs TAK, ZTS, HLN, TEVA, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
COLL Collegium Pharmaceutical Inc	32.31	1.03B	780.57M	62.87M	327.58M	1.7171
TAK Takeda Pharmaceutical Co Adr	18.74	59.20B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	117.94	49.79B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	9.93	44.27B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	30.08	35.03B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	564.81	24.75B	3.18B	1.33B	1.04B	27.90

Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-12-09	Iniziato	Barclays	Overweight
2025-01-10	Aggiornamento	Needham	Hold → Buy
2024-07-30	Aggiornamento	H.C. Wainwright	Neutral → Buy
2024-06-07	Aggiornamento	Jefferies	Hold → Buy
2024-05-10	Downgrade	Needham	Buy → Hold
2024-05-10	Downgrade	Piper Sandler	Overweight → Neutral
2024-01-04	Downgrade	Jefferies	Buy → Hold
2023-08-25	Reiterato	Needham	Buy
2023-05-02	Ripresa	Jefferies	Buy
2022-08-08	Downgrade	H.C. Wainwright	Buy → Neutral
2022-02-15	Aggiornamento	Cantor Fitzgerald	Neutral → Overweight
2021-08-06	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2021-01-11	Reiterato	H.C. Wainwright	Buy
2020-07-14	Iniziato	BWS Financial	Sell
2020-05-27	Iniziato	Guggenheim	Neutral
2020-02-19	Ripresa	Jefferies	Buy
2019-10-30	Reiterato	Needham	Buy
2019-05-03	Ripresa	H.C. Wainwright	Buy
2019-04-12	Ripresa	Janney	Buy
2019-03-20	Iniziato	SunTrust	Hold
2019-01-16	Reiterato	Needham	Buy
2018-03-08	Reiterato	H.C. Wainwright	Buy
2018-02-07	Reiterato	Needham	Buy
2017-12-05	Reiterato	Needham	Buy
2017-09-11	Iniziato	H.C. Wainwright	Buy
2017-05-11	Reiterato	Needham	Buy
2016-09-13	Iniziato	Gabelli & Co	Buy
2015-06-01	Iniziato	Jefferies	Buy
2015-06-01	Iniziato	Needham	Buy
2015-06-01	Iniziato	Piper Jaffray	Overweight

Mostra tutto

Collegium Pharmaceutical Inc Borsa (COLL) Ultime notizie

Collegium Pharmaceutical Inc Azioni (COLL) Dati Finanziari

Collegium Pharmaceutical Inc (COLL)

Collegium Pharmaceutical Inc Stock (COLL) Company Profile

Compare COLL vs TAK, ZTS, HLN, TEVA, UTHR

Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades

Collegium Pharmaceutical Inc Borsa (COLL) Ultime notizie

Chipmakers Recap: Should I hold or sell Collegium Pharmaceutical Inc now2026 Highlights & Reliable Volume Spike Alerts - baoquankhu1.vn

COLL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Collegium Pharmaceutical (COLL) Valuation Check After Recent Share Price Pullback - Sahm

Is Collegium Pharmaceutical (COLL) one of the best small-cap drug manufacturers? - MSN

Collegium (COLL) EVP has 8,840 shares withheld for RSU tax payment - Stock Titan

Collegium Pharmaceutical (COLL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan

GE HealthCare and Collegium Pharmaceutical Stocks Trade Down, What You Need To Know - Yahoo Finance

COLL Stock Price, Quote & Chart | COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) - ChartMill

Collegium Pharmaceutical (COLL) surged following record quarterly results - MSN

Collegium Pharmaceutical, Inc. (COLL) Stock Forecasts - finance.yahoo.com

Collegium Pharmaceutical EVP Sells Nearly 50,000 Shares Worth $2 Million - AOL.com

Collegium Pharma Executive David Dieter Sells Shares in March 2026News and Statistics - IndexBox

Collegium Pharmaceutical Acquires AZSTARYS for $650M - National Today

Is Collegium Pharmaceutical (COLL) One of the Best Small-Cap Drug Manufacturers - Insider Monkey

Aug Volume: Can Collegium Pharmaceutical Inc be the next market leaderSell Signal & AI Enhanced Trading Alerts - baoquankhu1.vn

JPMorgan Chase & Co. Acquires 139,689 Shares of Collegium Pharmaceutical, Inc. $COLL - MarketBeat

Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD - The Motley Fool

Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD - The Motley Fool

Wedge Capital Management L L P NC Acquires New Stake in Collegium Pharmaceutical, Inc. $COLL - MarketBeat

Published on: 2026-03-30 05:44:15 - baoquankhu1.vn

Collegium Pharmaceutical Inc (NASDAQ:COLL) Presents a Compelling Value Investment Case - ChartMill

COLL SEC FilingsCollegium Pharmaceutical Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Is It Time To Reassess Collegium Pharmaceutical (COLL) After The Recent Share Price Pullback? - simplywall.st

Collegium’s AZSTARYS Deal And Insider Sale Put Focus On Valuation - Yahoo Finance

Vanguard disaggregates holdings; reports 0 shares in Collegium (COLL) - Stock Titan

Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL) - Yahoo Finance

Collegium Pharmaceutical, Inc. $COLL Shares Bought by Assenagon Asset Management S.A. - MarketBeat

Collegium Pharmaceutical, Inc. (COLL) to Present 9 Pain Studies at PAINWeek 2025 - MSN

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Medline (MDLN) and Collegium Pharmaceutical (COLL) - The Globe and Mail

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate GrowthSlideshow (NASDAQ:COLL) 2026-03-24 - Seeking Alpha

Collegium Pharmaceutical Stock Gains Momentum After Key Debt Repayment and Strong Earnings Momentum - ad-hoc-news.de

Collegium Pharmaceutical (COLL) Valuation Check After Recent Share Price Volatility - Sahm

Collegium to buy ADHD medicine Azstarys for up to $785M - MSN

Insider Selling: Collegium Pharmaceutical (NASDAQ:COLL) EVP Sells 13,976 Shares of Stock - MarketBeat

Dieter David, Collegium Pharmaceutical EVP, sells $488k in stock By Investing.com - Investing.com Canada

Dieter David, Collegium Pharmaceutical EVP, sells $488k in stock - investing.com

Collegium (NASDAQ: COLL) EVP trades 13,976 shares under 10b5-1 plan - Stock Titan

Collegium Pharmaceuticals: Another M&A Episode Adds To An Intriguing Case (NASDAQ:COLL) - Seeking Alpha

Collegium Pharmaceutical stock faces scrutiny amid opioid market shifts and regulatory pressures - AD HOC NEWS

Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to Acquire Azstarys from Corium Therapeutics - Pharmaceutical Executive

Azstarys (re-)born with Collegium’s ADHD buy - BioWorld MedTech

Collegium Pharmaceutical Expands ADHD Portfolio With AZSTARYS And Valuation Gap - simplywall.st

Needham & Company LLC Reiterates Buy Rating for Collegium Pharmaceutical (NASDAQ:COLL) - MarketBeat

Collegium Pharmaceutical (NASDAQ:COLL) Given Buy Rating at HC Wainwright - MarketBeat

Collegium to acquire Azstarys from Corium Therapeutics - The Pharma Letter

Collegium Pharmaceutical to Acquire AZSTARYS® for $650 Million, Expanding ADHD Portfolio and Projecting Over $50 Million Revenue in Late 2026 - Minichart

Collegium Pharmaceutical to acquire AZSTARYS for $650 million By Investing.com - Investing.com Australia

Jefferies reiterates Collegium Pharmaceutical stock Buy on ADHD deal By Investing.com - Investing.com Canada

Collegium Pharmaceutical to Acquire AZSTARYS ADHD Franchise - TipRanks

Collegium (NASDAQ: COLL) to acquire AZSTARYS in $650M ADHD expansion deal - Stock Titan

Collegium Pharmaceutical Inc Azioni (COLL) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a COLL